Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows that no participants are being recruited and adds user-focused sections such as How to Read a Study Record, Common Questions, and How to Join a Study, while updating the Intervention/Treatment heading formatting.
    Difference
    0.4%
    Check dated 2026-06-13T17:35:47.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision label at the bottom of the page changed from v3.5.4 to v3.5.5, reflecting a small update to the page.
    Difference
    0.0%
    Check dated 2026-06-06T14:27:35.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.5.4 is now listed, replacing the previous v3.5.3, indicating a new version of the related document or protocol.
    Difference
    0.0%
    Check dated 2026-05-15T23:44:59.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:28:57.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:50:36.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:56:24.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.